Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 3;10(2):e05289.
doi: 10.1002/ccr3.5289. eCollection 2022 Feb.

Hemodynamic variation is a dominant contributing factor of Graves' hyperthyroidism complication: Heart failure and fatal liver dysfunction, a case report and analysis

Affiliations
Case Reports

Hemodynamic variation is a dominant contributing factor of Graves' hyperthyroidism complication: Heart failure and fatal liver dysfunction, a case report and analysis

Zhiyuan Li et al. Clin Case Rep. .

Erratum in

  • Erratum:
    [No authors listed] [No authors listed] Clin Case Rep. 2022 May 27;10(5):e05763. doi: 10.1002/ccr3.5763. eCollection 2022 May. Clin Case Rep. 2022. PMID: 35664518 Free PMC article.

Abstract

Tachycardia and atrial fibrillation, early symptoms of hyperthyroidism indicate significant hemodynamic variation in cardiovascular system, if left untreated and further deterioration in hemodynamics can result in chronic heart failure and liver dysfunction even a fatal event. We describe a female patient of Graves' hyperthyroidism to present the continuum of the pathophysiology development of the disease, to highlight the hemodynamic variation is a dominant contributing factor of Graves' hyperthyroidism complication, we wish to emphasize cardiac manifestations in the setting of thyrotoxicosis should be treated promptly and aggressively.

Keywords: Graves' hyperthyroidism; atrial fibrillation; fatal liver dysfunction; heart failure; hemodynamic variation; tachycardia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

FIGURE 1
FIGURE 1
ECG and chest radiography on admission. (A) ECG showing atrial fibrillation and a heart rate of 80 beats/min (treated with metoprolol, 25 mg 2/day). (B) Chest radiography showing right pleural effusion and pulmonary congestion, the cardiothoracic ratio was 72%
FIGURE 2
FIGURE 2
Transthoracic echocardiogram reported (A) bilateral atrial and right ventricle enlargement with an left ventricular ejection fraction of 60%, (B) severe mitral and tricuspid regurgitation with elevated pulmonary artery pressure. CO, cardiac output; LA, left atrium; LV, left ventricle; LVDd, left ventricular end‐diastolic dimension; LVEF, left ventricular ejection fraction; PAP, pulmonary arterial pressure; RA, right atrium; RV, right ventricle; RVDd, right ventricular end‐diastolic dimension; SV, stroke volume
FIGURE 3
FIGURE 3
Serial levels of biochemical parameters during hospitalization. ALT, alanine aminotransferase; DBil, direct bilirubin; FT3, free triiodothyronine; FT4, free thyroxine; PTA, prothrombin activity; TBIL, total bilirubin

Similar articles

Cited by

References

    1. Leo SD, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906‐918. - PMC - PubMed
    1. Biondi B. Heart failure and thyroid dysfunction. Eur J Endocrinol. 2012;167(609–618):2012. - PubMed
    1. Dahl P, Danzi S, Klein I. Thyrotoxic cardiac disease. Curr Heart Fail Rep. 2008;5:170‐176. - PubMed
    1. Brent G. The molecular basis of thyroid hormone action. N Engl J Med. 1994;331:847‐853. - PubMed
    1. Danzi S, Klein I. Thyroid hormone and the cardiovascular system. Minerva Endocrinol. 2004;29:139‐150. - PubMed

Publication types

LinkOut - more resources